RecruitingPhase 3NCT07398846
Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
A 12-Week Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
Sponsor
Colgate Palmolive
Enrollment
135 participants
Start Date
Jan 26, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate the efficacy of a stannous fluoride toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Inclusion Criteria7
- Signed Informed Consent Form.
- Male and female subjects aged 18-70 years, inclusive.
- Availability for the twelve-week duration of the clinical research study.
- Good general health based on the opinion of the study investigator
- Minimum of 20 permanent natural teeth (excluding third molars).
- Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
- Initial mean plaque index of at least 0.6 as determined by Rustogi Modification of the Navy plaque index.
Exclusion Criteria13
- Presence of orthodontic appliances;
- Presence of partial removable dentures;
- Oral pathology, chronic disease or tumor(s) of the soft or hard tissues of the oral cavity; 4. Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone);
- Five or more carious lesions requiring immediate restorative treatment;
- Use of anticonvulsants, sedatives, tranquilizers, anti-inflammatory or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study;
- Use of antibiotics any time during the one-month period prior to entry into the study;
- Ongoing use of medications known to affect the gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine) and/or on any prescription medicines that might interfere with the study outcome;
- Participation in any other clinical study;
- Self-reported pregnancy and/or breastfeeding;
- Dental prophylaxis within the past three weeks prior to baseline examinations;
- Current allergies and/or history of allergic reactions to oral care products, personal care consumer products, or any of their ingredients;
- An existing medical condition that prohibits eating and/or drinking for periods up to 4 hours;
- Current smokers and/or a history of alcohol or drug abuse
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUG0.454%Stannous fluoride toothpaste
toothpaste
DRUG0.075% Cetylpyridinium Chloride (CPC) and 0.28% zinc lactatmouthwashe
mouthwash
DRUG0.76% Sodium Monofluorophosphate (Na MFP) toothpaste
toothpaste
DRUG0.022% Sodium Fluoride mouthwash
mouthwash
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07398846
Related Trials
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
NCT069393743 locations
Comparison of the Effects of Oral Hygiene Regimens on Clinical, Immunomodulatory, and Microbial Outcomes and Oral Tolerance in People With Gingivitis
NCT075014551 location